Impact analysis of COVID-19 on Global Medical Devices used for Opioid Use Disorder and Drug Addiction Treatment Market Outlook 2027
Published Date:May 2020 (Upgradation in process)
Category:Healthcare & Pharmaceuticals
Impact Analysis on the Growth of Market
Activating Probable Propositions Amidst COVID-19 Crisis
With things going haywire, we analyze key points to make sure that the businesses around the globe are completely prepared to tackle potential implications caused by COVID-19. Be it protecting employees, customers or the overall business operations, we ensure that the employers take the right decisions, make strategic investments and maintain a healthy work culture along with taking probable measures to minimize the financial loss. Know More
Medical Devices Used For Opioid Use Disorder and Drug Addiction Treatment Market Analysis – 2020-2027
There are certain medical devices that are used to treat opioid use disorder as well as drug addiction. These can be broadly classified into wearable devices and non-wearable devices. The highest demand for medical devices is observed by Drug Relief by DyAnsys and NSS-2 BRIDGE by Innovative Health Solutions, Inc. (IHS). They are both Class II medical devices with percutaneous electrical nerve field stimulator (PNFS) systems that reduce the symptoms of opioid withdrawal. The market for medical devices used for opioid use disorder and drug addiction treatment is projected to grow by a significant CAGR of 16.86% during the forecast period, i.e., 2020-2027. It is anticipated to reach a market value of USD 21.85 million by the end of 2027.
The market is segmented by product into wearable devices and non-wearable devices, out of which, the segment for wearable devices is anticipated to hold the leading share in the market as a result of increasing availability of wearable devices. The wearable devices segment is anticipated to attain a higher market size of USD 19.79 million by 2027. In addition to this, the high demand for wearable devices as they are easy to use is another factor contributing towards the large share of wearable devices segment in the market.
The medical devices used for opioid use disorder and drug addiction treatment market is segmented on the basis of region into North America, Europe, Asia Pacific, Latin America and Middle East and South Africa. On the basis of region, the market in North America is anticipated to hold the leading share along with the highest growth, which is predicted to be observed by the market in North America with a CAGR of 18.48% over the forecast period. This can be attributed to the presence of leading companies in the region as well as generation of maximum revenue from these medical devices in the United States.
Some of the key industry leaders in the global medical devices used for opioid use disorder and drug addiction treatment market are DyAnsys Inc., Innovative Health Solutions Inc., SPARK BIOMEDICAL, INC, Brainsway, EvON Medics and Pear Therapeutics, Inc.
Global Medical Devices Used for Opioid Use Disorder & Drug Addiction Treatment Market
Table of Contents
Part 1 Introduction
Part 2 Market Segmentation By Product (Wearable & Non-Wearable Devices)
Part 3 Market Scenario of Medical Devices Used for Opioid Use Disorder & Drug Addiction
Part 4 Global Market Analysis, By Region
• North America
• Asia Pacific
Part 5 Global Market Analysis, By Product (Wearable & Non-Wearable Devices)
• North America
• Asia Pacific
Part 6 Global Digital Therapeutics Used for Opioid Use Disorder & Drug Addiction Treatment Market
Part 7 Recent News & Development
Part 8 Company Profiles
• Innovative Health Solutions INC
• Spark Biomedical Inc.
• Brainsway Ltd.
• EvON Medics
• Pear Therapeutics Inc.
Please enter your personal details below
DyAnsys Inc., Innovative Health Solutions Inc., SPARK BIOMEDICAL, INC, Brainsway, EvON Medics and Pear Therapeutics, Inc.